Literature DB >> 25111906

Ellagitannins as synergists of ACV on the replication of ACV-resistant strains of HSV 1 and 2.

N Vilhelmova-Ilieva1, R Jacquet2, S Quideau2, A S Galabov3.   

Abstract

The plant-derived polyphenolic compounds castalagin, vescalagin and grandinin (C-glucosidic ellagitannins containing nonahydroxyterphenoyl) manifested a strong inhibitory effect on the replication of acyclovir-resistant strains of herpes simplex viruses (HSV) type 1 and 2 in MDBK cells in focus forming units (i.e., microscopically registered microplaques) reduction assay and in two variants of cytopathic effect inhibition test. The effect on the acyclovir (ACV)-resistant herpes simplex virus type 1 (HSV-1) strain was markedly higher compared to that on the ACV-resistant herpes simplex virus type 2 (HSV-2). The three compounds showed comparable levels of antiviral activity against ACV-resistant HSV strains, in contrast with previous results where castalagin exerted the highest degree of activity against wild type HSV strains (Vilhelmova et al., 2011). Combinations of ellagitannins and ACV were tested on the ACV-resistant strains of both HSV-1 and 2 and produced synergistic effects that were revealed by applying the three-dimensional approach of Prichard and Shipman (1990). The ellagitannin(s)-ACV combination applied against ACV-resistant HSV-1 produced a much stronger synergistic effect compared to the effect observed against ACV-resistant HSV-2. The study of the effects of the combination ellagitannin(s)-ACF on intact cell monolayers did not show any toxicity resulting from interaction between the two substances. Altogether, the results obtained in this study demonstrate the highly promising potential of these plant polyphenols as antiherpetic agents.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACV; ACV resistant strains; Antiviral; Ellagitannins; HSV-1; HSV-2

Mesh:

Substances:

Year:  2014        PMID: 25111906     DOI: 10.1016/j.antiviral.2014.07.017

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  7 in total

1.  Synergistic effects of acyclovir and 3, 19-isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains.

Authors:  Thongkoon Priengprom; Tipaya Ekalaksananan; Bunkerd Kongyingyoes; Supawadee Suebsasana; Chantana Aromdee; Chamsai Pientong
Journal:  BMC Complement Altern Med       Date:  2015-03-11       Impact factor: 3.659

2.  Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.

Authors:  David M J Houston; Joachim J Bugert; Stephen P Denyer; Charles M Heard
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

Review 3.  40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs?

Authors:  Anna Majewska; Beata Mlynarczyk-Bonikowska
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

4.  In Vitro Study of the Biological Potential of Wastewater Obtained after the Distillation of Four Bulgarian Oil-Bearing Roses.

Authors:  Yana Ilieva; Lyudmila Dimitrova; Almira Georgieva; Neli Vilhelmova-Ilieva; Maya Margaritova Zaharieva; Zlatina Kokanova-Nedialkova; Ana Dobreva; Paraskev Nedialkov; Vesselin Kussovski; Alexander D Kroumov; Hristo Najdenski; Milka Mileva
Journal:  Plants (Basel)       Date:  2022-04-14

Review 5.  Recent Advances in the Production and Applications of Ellagic Acid and Its Derivatives. A Review.

Authors:  Dmitry D Evtyugin; Sandra Magina; Dmitry V Evtuguin
Journal:  Molecules       Date:  2020-06-13       Impact factor: 4.411

6.  Antiviral effect of Chinese herbal prescription JieZe-1 on adhesion and penetration of VK2/E6E7 with herpes simplex viruses type 2.

Authors:  Qianni Duan; Tong Liu; Ping Yuan; Cong Huang; Qingqing Shao; Lijun Xu; Jun Sun; Guangyin Huang; Zhuo Chen
Journal:  J Ethnopharmacol       Date:  2019-11-16       Impact factor: 4.360

Review 7.  Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2.

Authors:  Arumugam Vijaya Anand; Balasubramanian Balamuralikrishnan; Mohandass Kaviya; Kathirvel Bharathi; Aluru Parithathvi; Meyyazhagan Arun; Nachiappan Senthilkumar; Shanmugam Velayuthaprabhu; Muthukrishnan Saradhadevi; Naif Abdullah Al-Dhabi; Mariadhas Valan Arasu; Mohammad Iqbal Yatoo; Ruchi Tiwari; Kuldeep Dhama
Journal:  Molecules       Date:  2021-03-22       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.